Axia Journal of Cardiology (AJC)| Aims and Scope

Open science is essential to solving the world’s urgent challenges

Aims and Scope – Axia Journal of Cardiology (AJC)

The Axia Journal of Cardiology (AJC) is a peer-reviewed, open-access journal dedicated to publishing high-quality research and clinical advancements in cardiology and cardiovascular medicine. Our mission is to provide a platform for cardiologists, cardiovascular surgeons, researchers, and healthcare professionals to share innovative research, improve patient outcomes, and advance the field of cardiovascular health.

Scope:

  • Cardiovascular Diseases – Epidemiology, prevention, and management of heart diseases, including coronary artery disease and heart failure.
  • Interventional Cardiology – Advances in percutaneous coronary interventions, stents, and catheter-based treatments.
  • Electrophysiology and Arrhythmias – Diagnosis and treatment of atrial fibrillation, ventricular arrhythmias, and pacemaker technology.
  • Cardiac Imaging – Innovations in echocardiography, cardiac MRI, CT angiography, and nuclear cardiology.
  • Heart Failure and Cardiomyopathies – Pathophysiology, novel therapies, and heart transplant advancements.
  • Hypertension and Vascular Medicine – Blood pressure management, endothelial function, and vascular diseases.
  • Preventive Cardiology and Lipid Management – Risk factor modification, cholesterol control, and lifestyle interventions.
  • Congenital Heart Diseases – Pediatric and adult congenital heart disease diagnosis and treatment.
  • Cardiac Surgery – Coronary artery bypass grafting (CABG), valve repair, and minimally invasive heart surgeries.
  • Peripheral Vascular Disease – Diagnosis and management of arterial and venous disorders.
  • Cardio-Oncology – Cardiovascular effects of cancer treatments and strategies for heart protection.
  • Sports Cardiology – Cardiac evaluation of athletes, sudden cardiac arrest prevention, and exercise physiology.
  • Artificial Intelligence and Digital Health in Cardiology – AI applications, wearable technologies, and remote monitoring.
  • Cardiometabolic Disorders – The intersection of diabetes, obesity, and heart disease.
  • Stem Cell Therapy and Regenerative Medicine in Cardiology – Advances in myocardial regeneration and tissue engineering.

AJC serves cardiologists, cardiovascular surgeons, electrophysiologists, researchers, medical professionals, and healthcare policymakers focused on advancing heart health and cardiovascular care.

The journal follows a rigorous peer-review process, ensures international visibility through indexing in major scientific databases, and promotes rapid publication to disseminate high-impact research in cardiology.